Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Needham & Company LLC 

Atricure Inc. diskutieren

Atricure Inc.

WKN: A0ES9W / Symbol: ATRC / Name: AtriCure / Aktie / Ausrüstung & Versorgung / Small Cap /

34,20 €
3,01 %

Einschätzung Buy
Rendite (%) 3,79 %
Kursziel 36,85
Veränderung
Endet am 30.10.25

AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at UBS Group AG from $35.00 to $40.00. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat

Einschätzung Buy
Rendite (%) 3,79 %
Kursziel 36,83
Veränderung
Endet am 30.10.25

AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at JPMorgan Chase & Co. from $30.00 to $40.00. They now have an "overweight" rating on the stock.
Ratings data for ATRC provided by MarketBeat

Einschätzung Buy
Rendite (%) 3,79 %
Kursziel 33,14
Veränderung
Endet am 30.10.25

AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Oppenheimer Holdings Inc. from $32.00 to $36.00. They now have an "outperform" rating on the stock.
Ratings data for ATRC provided by MarketBeat

Einschätzung Buy
Rendite (%) 17,45 %
Kursziel 38,06
Veränderung
Endet am 17.12.25

AtriCure, Inc. (NASDAQ: ATRC) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $40.00 price target on the stock.
Ratings data for ATRC provided by MarketBeat

Einschätzung Buy
Rendite (%) 5,16 %
Kursziel 39,22
Veränderung
Endet am 13.01.26

AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $40.00 price target on the stock.
Ratings data for ATRC provided by MarketBeat

Einschätzung Buy
Rendite (%) 16,76 %
Kursziel 48,86
Veränderung
Endet am 22.01.26

AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Needham & Company LLC from $40.00 to $51.00. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat

Einschätzung Buy
Rendite (%) 16,76 %
Kursziel 49,31
Veränderung
Endet am 11.02.26

AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at JPMorgan Chase & Co. from $40.00 to $51.00. They now have an "overweight" rating on the stock.
Ratings data for ATRC provided by MarketBeat

Einschätzung Buy
Rendite (%) 16,76 %
Kursziel 49,06
Veränderung
Endet am 13.02.26

AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $51.00 price target on the stock.
Ratings data for ATRC provided by MarketBeat

Einschätzung Buy
Rendite (%) 16,76 %
Kursziel 46,14
Veränderung
Endet am 13.02.26

AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Stifel Nicolaus from $36.00 to $48.00. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat

Einschätzung Buy
Rendite (%) 16,76 %
Kursziel 47,87
Veränderung
Endet am 13.02.26

AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Piper Sandler from $40.00 to $50.00. They now have an "overweight" rating on the stock.
Ratings data for ATRC provided by MarketBeat

Einschätzung Buy
Rendite (%) 16,76 %
Kursziel 43,15
Veränderung
Endet am 13.02.26

AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Oppenheimer Holdings Inc. from $36.00 to $45.00. They now have an "outperform" rating on the stock.
Ratings data for ATRC provided by MarketBeat

Einschätzung Buy
Rendite (%) 16,76 %
Kursziel 47,00
Veränderung
Endet am 21.03.26

AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $51.00 price target on the stock.
Ratings data for ATRC provided by MarketBeat

Einschätzung Buy
Rendite (%) 16,76 %
Kursziel 47,37
Veränderung
Endet am 27.03.26

AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $51.00 price target on the stock.
Ratings data for ATRC provided by MarketBeat

Einschätzung Buy
Rendite (%) 16,76 %
Kursziel 42,73
Veränderung
Endet am 27.03.26

AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at JPMorgan Chase & Co. from $51.00 to $46.00. They now have an "overweight" rating on the stock.
Ratings data for ATRC provided by MarketBeat

Einschätzung Buy
Rendite (%) 16,76 %
Kursziel 38,70
Veränderung
Endet am 30.04.26

AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at Needham & Company LLC from $51.00 to $44.00. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat

Einschätzung Buy
Rendite (%) 16,76 %
Kursziel 51,01
Veränderung
Endet am 30.04.26

AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at UBS Group AG from $60.00 to $58.00. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat

Einschätzung Buy
Rendite (%) 16,76 %
Kursziel 38,90
Veränderung
Endet am 30.07.26

AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Needham & Company LLC from $44.00 to $45.00. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat

Einschätzung Buy
Rendite (%) -1,16 %
Kursziel 40,85
Veränderung
Endet am 16.12.26

AtriCure (NASDAQ:ATRC) had its price target raised by analysts at JPMorgan Chase & Co. from $42.00 to $48.00. They now have an "overweight" rating on the stock.
Ratings data for ATRC provided by MarketBeat